HIF-1alpha is essential for myeloid cell-mediated inflammation. Cramer T, Yamanishi Y, Clausen BE, Förster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V, Firestein GS, Gerber HP, Ferrara N, Johnson RS (2003) Cell 112: 645-57 Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. Yoneda J, Kuniyasu H, Crispens MA, Price JE, Bucana CD, Fidler IJ (1998) J Natl Cancer Inst 90: 447-54 Host cyclooxygenase-2 modulates carcinoma growth. Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN (2000) J Clin Invest 105: 1589-94 Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. Grant MB, Tarnuzzer RW, Caballero S, Ozeck MJ, Davis MI, Spoerri PE, Feoktistov I, Biaggioni I, Shryock JC, Belardinelli L (1999) Circ Res 85: 699-706 Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Ushio-Fukai M, Tang Y, Fukai T, Dikalov SI, Ma Y, Fujimoto M, Quinn MT, Pagano PJ, Johnson C, Alexander RW (2002) Circ Res 91: 1160-7 Mast cell-mediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors. Feoktistov I, Ryzhov S, Goldstein AE, Biaggioni I (2003) Circ Res 92: 485-92 Differential expression of adenosine receptors in human endothelial cells: role of A2B receptors in angiogenic factor regulation. Feoktistov I, Goldstein AE, Ryzhov S, Zeng D, Belardinelli L, Voyno-Yasenetskaya T, Biaggioni I (2002) Circ Res 90: 531-8 Promises and pitfalls of anti-angiogenic therapy in clinical trials. McCarty MF, Liu W, Fan F, Parikh A, Reimuth N, Stoeltzing O, Ellis LM (2003) Trends Mol Med 9: 53-8 Leukemia inhibitory factor upregulates cytokine expression by a murine stromal cell line enabling the maintenance of highly enriched competitive repopulating stem cells. Szilvassy SJ, Weller KP, Lin W, Sharma AK, Ho AS, Tsukamoto A, Hoffman R, Leiby KR, Gearing DP (1996) Blood 87: 4618-28 In vivo intracellular signaling as a marker of antiangiogenic activity. Solorzano CC, Jung YD, Bucana CD, McConkey DJ, Gallick GE, McMahon G, Ellis LM (2001) Cancer Res 61: 7048-51 Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells. Dikov MM, Oyama T, Cheng P, Takahashi T, Takahashi K, Sepetavec T, Edwards B, Adachi Y, Nadaf S, Daniel T, Gabrilovich DI, Carbone DP (2001) Cancer Res 61: 2015-21 Repetitive weekly cycles of interleukin 2: effect of outpatient treatment with a lower dose of interleukin 2 on non-major histocompatibility complex-restricted killer activity. Goldstein D, Sosman JA, Hank JA, Weil-Hillman G, Moore KH, Borchert A, Bechhofer R, Storer B, Kohler PC, Levitt D (1989) Cancer Res 49: 6832-9 Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. Geng L, Donnelly E, McMahon G, Lin PC, Sierra-Rivera E, Oshinka H, Hallahan DE (2001) Cancer Res 61: 2413-9 Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype. Weil-Hillman G, Voss SD, Fisch P, Schell K, Hank JA, Sosman JA, Sugamura K, Sondel PM (1990) Cancer Res 50: 2683-91 The role of autoreactive T-cell lines in the restoration of the immune response to sheep red blood cells in C57Bl/6-lpr/lpr mice. Latta SL, Sosman JA, Quintans J (1989) J Autoimmun 2: 15-24 Optimization for the blockade of epidermal growth factor receptor signaling for therapy of human pancreatic carcinoma. Solorzano CC, Baker CH, Tsan R, Traxler P, Cohen P, Buchdunger E, Killion JJ, Fidler IJ (2001) Clin Cancer Res 7: 2563-72 Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions. Zebrowski BK, Yano S, Liu W, Shaheen RM, Hicklin DJ, Putnam JB, Ellis LM (1999) Clin Cancer Res 5: 3364-8 A phase I trial of continuous infusion interleukin-4 (IL-4) alone and following interleukin-2 (IL-2) in cancer patients. Sosman JA, Fisher SG, Kefer C, Fisher RI, Ellis TM (1994) Ann Oncol 5: 447-52 Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Brantley DM, Cheng N, Thompson EJ, Lin Q, Brekken RA, Thorpe PE, Muraoka RS, Cerretti DP, Pozzi A, Jackson D, Lin C, Chen J (2002) Oncogene 21: 7011-26 Antiangiogenic agents are effective inhibitors of endometriosis. Hull ML, Charnock-Jones DS, Chan CL, Bruner-Tran KL, Osteen KG, Tom BD, Fan TP, Smith SK (2003) J Clin Endocrinol Metab 88: 2889-99 TRF requirements for in vitro PFC responses to SRBC and R36a. I. TRF is distinct from IL 2 but indistinguishable from polyclonal BCSF. Eisenberg L, Prystowsky MB, Dick RF, Sosman JA, Fitch FW, Quintáns J (1984) J Immunol 132: 1305-10 Differences in DNA sequence specificity among MHC class II X box binding proteins. Boothby M, Liou HC, Glimcher LH (1989) J Immunol 142: 1005-14 CD8+ T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo. Assarsson E, Kambayashi T, Sandberg JK, Hong S, Taniguchi M, Van Kaer L, Ljunggren HG, Chambers BJ (2000) J Immunol 165: 3673-9 NF-kappa B/Rel participation in the lymphokine-dependent proliferation of T lymphoid cells. Mora A, Youn J, Keegan A, Boothby M (2001) J Immunol 166: 2218-27 Hypoxia-induced gene expression occurs solely through the action of hypoxia-inducible factor 1alpha (HIF-1alpha): role of cytoplasmic trapping of HIF-2alpha. Park SK, Dadak AM, Haase VH, Fontana L, Giaccia AJ, Johnson RS (2003) Mol Cell Biol 23: 4959-71 The influence of autologous lymphokine-activated killer cell infusions on the toxicity and antitumor effect of repetitive cycles of interleukin-2. Albertini MR, Sosman JA, Hank JA, Moore KH, Borchert A, Schell K, Kohler PC, Bechhofer R, Storer B, Sondel PM (1990) Cancer 66: 2457-64 Angiopoietin-1 inhibits tumour growth and ascites formation in a murine model of peritoneal carcinomatosis. Stoeltzing O, Ahmad SA, Liu W, McCarty MF, Parikh AA, Fan F, Reinmuth N, Bucana CD, Ellis LM (2002) Br J Cancer 87: 1182-7 Induction of neuropilin-1 and vascular endothelial growth factor by epidermal growth factor in human gastric cancer cells. Akagi M, Kawaguchi M, Liu W, McCarty MF, Takeda A, Fan F, Stoeltzing O, Parikh AA, Jung YD, Bucana CD, Mansfield PF, Hicklin DJ, Ellis LM (2003) Br J Cancer 88: 796-802 Murine platelet endothelial cell adhesion molecule (PECAM-1)/CD31 modulates beta 2 integrins on lymphokine-activated killer cells. Piali L, Albelda SM, Baldwin HS, Hammel P, Gisler RH, Imhof BA (1993) Eur J Immunol 23: 2464-71 Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer. Stoeltzing O, Liu W, Reinmuth N, Fan F, Parikh AA, Bucana CD, Evans DB, Semenza GL, Ellis LM (2003) Am J Pathol 163: 1001-11 Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis. Cheng N, Brantley DM, Liu H, Lin Q, Enriquez M, Gale N, Yancopoulos G, Cerretti DP, Daniel TO, Chen J (2002) Mol Cancer Res 1: 2-11 Antiangiogenic therapy targeting factors that enhance endothelial cell survival. Liu W, Reinmuth N, Stoeltzing O, Parikh AA, Fan F, Ahmad SA, Jung YD, Ellis LM (2002) Semin Oncol 29: 96-103 In vivo activation of lymphokine-activated killer activity with interleukin-2: prospects for combination therapies. Sosman JA, Hank JA, Sondel PM (1990) Semin Oncol 17: 22-30; discussion 38-41 Role of angiogenesis in the development and growth of liver metastasis. Takeda A, Stoeltzing O, Ahmad SA, Reinmuth N, Liu W, Parikh A, Fan F, Akagi M, Ellis LM (2002) Ann Surg Oncol 9: 610-6 Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer. Reinmuth N, Fan F, Liu W, Parikh AA, Stoeltzing O, Jung YD, Bucana CD, Radinsky R, Gallick GE, Ellis LM (2002) Lab Invest 82: 1377-89 Vascular endothelial growth factor is increased in devascularized rat islets of Langerhans in vitro. Gorden DL, Mandriota SJ, Montesano R, Orci L, Pepper MS (1997) Transplantation 63: 436-43 Ciliary neurotrophic factor blocks rod photoreceptor differentiation from postmitotic precursor cells in vitro. Kirsch M, Schulz-Key S, Wiese A, Fuhrmann S, Hofmann H (1998) Cell Tissue Res 291: 207-16 Endothelial survival factors as targets for antineoplastic therapy. Reinmuth N, Stoeltzing O, Liu W, Ahmad SA, Jung YD, Fan F, Parikh A, Ellis LM (2001) Cancer J 7 Suppl 3: S109-19 Addition of interleukin-2 in vitro augments detection of lymphokine-activated killer activity generated in vivo. Hank JA, Weil-Hillman G, Surfus JE, Sosman JA, Sondel PM (1990) Cancer Immunol Immunother 31: 53-9 Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. Ben-Av P, Crofford LJ, Wilder RL, Hla T (1995) FEBS Lett 372: 83-7
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.